South Korea's Ministry of Science and ICT official is investigating a potential hack into a state-run Korea Atomic Energy Research Institute by a group suspected to be associated with a North Korean intelligence agency.
Lawmaker Ha Tae-keung of the main opposition People Power Party identified the hackers as belonging to the North Korean group.
The hack occurred after the nuclear research institute's network was breached multiple times between May 14 to 31.
The institute has since taken security measures, such as stopping its virtual private network and blocking the hacker's internet protocol address.
The science ministry is currently examining the extent of the hacking incident and the source of the attack.


SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
Asian Technology and Chipmaking Stocks Slide as AI Spending Concerns Shake Markets
Neuralink Expands Brain Implant Trials with 12 Global Patients
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life
U.S. Dollar Steadies Near October Lows as Rate Cut Expectations Keep Markets on Edge
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Asian Stocks Edge Higher as Tech Recovers, U.S. Economic Uncertainty Caps Gains
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Oil Prices Slip in Asia as 2026 Supply Glut Fears and Russia-Ukraine Talks Weigh on Markets
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Asian Stocks Slide as AI Valuation Fears and BOJ Uncertainty Weigh on Markets
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 



